PROK as of Nov 3 · 17:36 ET
PROKNasdaqBiological Products, (No Diagnostic Substances)
Prokidney Corp. · Brief
Next report
6 days
Nov 9 · after closeest.Q3 FY26
Expected move
No implied move.
—≥ implied
Q2 FY26±58.0%▼−4.73%×0.08
quarterimplied−60%0+60%realized×
Q2 FY26±58.0%▼−4.73%×0.08
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2
70managers reporting a position in the latest quarterly filings hold widespread stakes13F · Jun 30 '26
+14.01%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2
11managers whose positions together make up four fifths of the reported value dominate holdings13F · Jun 30 '26
5 of 23of the largest reporting managers cut their stake in the latest quarter reducing confidence13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
PROK report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.